Investing.com - Biondvax Pharma ADR reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Biondvax Pharma ADR announced earnings per share of ₪-0.005 on revenue of ₪0.00. Analysts polled by Investing.com anticipated EPS of ₪-0.17 on revenue of ₪0.00.
Biondvax Pharma ADR shares are down 42.55% from the beginning of the year, still down 67.63% from its 52 week high of ₪4.17 set on July 28, 2021. They are under-performing the Nasdaq which is down 22.02% from the start of the year.
Biondvax Pharma ADR shares gained 0.75% in intra-day trade following the report.
Biondvax Pharma ADR follows other major Healthcare sector earnings this month
Biondvax Pharma ADR's report follows an earnings beat by Pfizer on May 3, who reported EPS of ₪1.62 on revenue of ₪25.66B, compared to forecasts EPS of ₪1.49 on revenue of ₪24.1B.
Medtronic had missed expectations on May 26 with fourth quarter EPS of ₪1.52 on revenue of ₪8.09B, compared to forecast for EPS of ₪1.56 on revenue of ₪8.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar